220 related articles for article (PubMed ID: 33319323)
1. Morphological damage in Sertoli, myoid and interstitial cells in a mouse model of mucopolysaccharidosis type I (MPS I).
do Nascimento CC; Aguiar O; Viana GM; D'Almeida V
Mol Biol Rep; 2021 Jan; 48(1):363-370. PubMed ID: 33319323
[TBL] [Abstract][Full Text] [Related]
2. Evidence that glycosaminoglycan storage and collagen deposition in the cauda epididymidis does not impair sperm viability in the Mucopolysaccharidosis type I mouse model.
do Nascimento CC; Aguiar O; Viana GM; D Almeida V
Reprod Fertil Dev; 2020 Feb; 32(3):304-312. PubMed ID: 31679559
[TBL] [Abstract][Full Text] [Related]
3. Morphologic description of male reproductive accessory glands in a mouse model of mucopolysaccharidosis type I (MPS I).
do Nascimento CC; Junior OA; D'Almeida V
J Mol Histol; 2020 Apr; 51(2):137-145. PubMed ID: 32162173
[TBL] [Abstract][Full Text] [Related]
4. Sexual behaviour in a murine model of mucopolysaccharidosis type I (MPS I).
Barbosa Mendes A; do Nascimento CC; D'Almeida V
PLoS One; 2019; 14(12):e0220429. PubMed ID: 31834922
[TBL] [Abstract][Full Text] [Related]
5. Analysis of male reproductive parameters in a murine model of mucopolysaccharidosis type I (MPS I).
do Nascimento CC; Junior OA; D'Almeida V
Int J Clin Exp Pathol; 2014; 7(6):3488-97. PubMed ID: 25031781
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation.
Wang D; Shukla C; Liu X; Schoeb TR; Clarke LA; Bedwell DM; Keeling KM
Mol Genet Metab; 2010 Jan; 99(1):62-71. PubMed ID: 19751987
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series.
Tebani A; Zanoutene-Cheriet L; Adjtoutah Z; Abily-Donval L; Brasse-Lagnel C; Laquerrière A; Marret S; Chalabi Benabdellah A; Bekri S
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196898
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin B-associated Activation of Amyloidogenic Pathway in Murine Mucopolysaccharidosis Type I Brain Cortex.
Viana GM; Gonzalez EA; Alvarez MMP; Cavalheiro RP; do Nascimento CC; Baldo G; D'Almeida V; de Lima MA; Pshezhetsky AV; Nader HB
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093427
[TBL] [Abstract][Full Text] [Related]
9. Neonatal tolerance induction enables accurate evaluation of gene therapy for MPS I in a canine model.
Hinderer C; Bell P; Louboutin JP; Katz N; Zhu Y; Lin G; Choa R; Bagel J; O'Donnell P; Fitzgerald CA; Langan T; Wang P; Casal ML; Haskins ME; Wilson JM
Mol Genet Metab; 2016 Sep; 119(1-2):124-30. PubMed ID: 27386755
[TBL] [Abstract][Full Text] [Related]
10. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
[TBL] [Abstract][Full Text] [Related]
11. Biomechanical and histological characterization of MPS I mice femurs.
Ferreira NY; do Nascimento CC; Pereira VG; de Oliveira F; Medalha CC; da Silva VC; D'Almeida V
Acta Histochem; 2021 Feb; 123(2):151678. PubMed ID: 33434858
[TBL] [Abstract][Full Text] [Related]
12. The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse.
Wang D; Belakhov V; Kandasamy J; Baasov T; Li SC; Li YT; Bedwell DM; Keeling KM
Mol Genet Metab; 2012 Jan; 105(1):116-25. PubMed ID: 22056610
[TBL] [Abstract][Full Text] [Related]
13. Differences in MPS I and MPS II Disease Manifestations.
Hampe CS; Yund BD; Orchard PJ; Lund TC; Wesley J; McIvor RS
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360653
[TBL] [Abstract][Full Text] [Related]
14.
De Filippis C; Napoli B; Rigon L; Guarato G; Bauer R; Tomanin R; Orso G
Cells; 2021 Dec; 11(1):. PubMed ID: 35011691
[TBL] [Abstract][Full Text] [Related]
15. Decreased performance in IDUA knockout mouse mimic limitations of joint function and locomotion in patients with Hurler syndrome.
Kim C; Kwak MJ; Cho SY; Ko AR; Rheey J; Kwon JY; Chung Y; Jin DK
Orphanet J Rare Dis; 2015 Sep; 10():121. PubMed ID: 26407983
[TBL] [Abstract][Full Text] [Related]
16. Identification of an α-l-iduronidase (IDUA) M1T mutation in a Chinese family with autosomal recessive mucopolysaccharidosis I.
Liu D; Jiang Z; Deng L; Li H; Jiang H
Ann N Y Acad Sci; 2023 Aug; 1526(1):114-125. PubMed ID: 37347427
[TBL] [Abstract][Full Text] [Related]
17. In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system.
Schuh RS; Poletto É; Pasqualim G; Tavares AMV; Meyer FS; Gonzalez EA; Giugliani R; Matte U; Teixeira HF; Baldo G
J Control Release; 2018 Oct; 288():23-33. PubMed ID: 30170069
[TBL] [Abstract][Full Text] [Related]
18. Nonviral in vivo gene transfer in the mucopolysaccharidosis I murine model.
Camassola M; Braga LM; Delgado-Cañedo A; Dalberto TP; Matte U; Burin M; Giugliani R; Nardi NB
J Inherit Metab Dis; 2005; 28(6):1035-43. PubMed ID: 16435197
[TBL] [Abstract][Full Text] [Related]
19. Impaired Hematopoiesis and Disrupted Monocyte/Macrophage Homeostasis in Mucopolysaccharidosis Type I Mice.
Viana GM; Buri MV; Paredes-Gamero EJ; Martins AM; D'Almeida V
J Cell Physiol; 2016 Mar; 231(3):698-707. PubMed ID: 26235607
[TBL] [Abstract][Full Text] [Related]
20. Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts.
Unger EG; Durrant J; Anson DS; Hopwood JJ
Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):43-9. PubMed ID: 7998955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
